Table 2. Characteristics of the Identified Studies (N = 12) on Adiponectin and Risk of Stroke.
| First author | Year | Cohort designation | Country | Follow-up (years) | Age, (Mean) (years) | % Men | Number of participantsa | Number of cases | Cohort design |
|---|---|---|---|---|---|---|---|---|---|
| Söderberg S36 | 2004 | MONICA | Sweden | 4.9 | 25–74 (54.9) | 57 | 828 | 276 | Nested case–control |
| Matsumoto M37 | 2008 | JMSCS | Japan | 9.7 | 19–93 (66) | 49 | 809 | 179 | Nested case–control |
| David J Stott38 | 2009 | PROSPER | UK | 3.2 | 70–82 (75.9) | 51 | 798 | 266 | Nested case–control |
| Ogorodnikova AD39 | 2010 | HaBPS | U.S. | 50–59 | 0 | 1701 | 855 | Nested case–control | |
| P. Khalili40 | 2010 | MPP | Sweden | 27 | (47) | 100 | 3512 | 373 | Prospective |
| Rajpathak SN41 | 2011 | WHI-OS | U.S. | 15–20 | 50–79 (68.7) | 0 | 1944 | 972 | Nested case–control |
| Prugger C42 | 2012 | PRIME | Northern Ireland and France | 10 | 50–59 (55.5) | 100 | 285 | 95 | Nested case–control |
| Wannamethee SG43 | 2013 | BRHS | UK | 9 | 60–79 (68.4) | 100 | 3411 | 192 | Prospective |
| Gardener H44 | 2013 | NOMAS | U.S. | 10 | (69) | 37 | 2900 | 269 | Prospective |
| Bidulescu A45 | 2013 | JHS | U.S. | 6.2 | 21–94 (54 ± 13) | 36 | 4571 | 87 | Prospective |
| Men | 100 | 31 | |||||||
| Women | 0 | 56 | |||||||
| Kizer JR46 | 2013 | CHS | U.S. | 10.5 | (74.4) | 37 | 3290 | 492 | Prospective |
| Arregui M11 | 2014 | EPIC | Germany | 8.2 | (50.1) | 37 | 2155 | 190 | Nested case–control |
| Men | 804 | 90 | |||||||
| Women | 1351 | 80 |
MONICA = Monitoring of Trends and Determinants in Cardiovascular Diseases; JMSCS = Jichi Medical School Cohort Study; PROSPER = Prospective Study of Pravastatin in the Elderly; HaBPS = Hormones and Biomarkers Predicting Stroke (HaBPS) ancillary study; MPP = Malmo Preventive Project; WHI-OS = Women’s Health Initiative Observational Study; PRIME = Prospective Epidemiological Study on Myocardial Infarction; BRHS = The British Regional Heart Study; NOMAS = the Northern Manhattan Study; JHS = Jackson Heart Study; CHS = Cardiovascular Health Study; EPIC = European Prospective Investigation into Cancer.